Display options
Share it on

Inflammopharmacology. 1997;5(3):219-36. doi: 10.1007/s10787-997-0001-1.

Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms.

Inflammopharmacology

M Malin, P Verronen, H Korhonen, E L Syväoja, S Salminen, H Mykkänen, H Arvilommi, E Eerola, E Isolauri

Affiliations

  1. Medical School, University of Tampere and Department of Paediatrics, Tampere University Hospital, Tampere, Finland.

PMID: 17638132 DOI: 10.1007/s10787-997-0001-1

Abstract

The effect of dietary therapy with a human Lactobacillus strain GG (ATCC 53103), bovine colostrum, or bovine immune colostrum with specific antibodies against anaerobic intestinal bacteria on gut defence mechanisms were studied in juvenile chronic arthritis. Thirty patients with juvenile chronic arthritis were randomly allocated to receive a freeze-dried powder of Lactobacillus GG, or bovine colostrum, or bovine immune colostrum, for a two-week period. Immunologic and non-immunologic gut defence mechanisms were indirectly investigated in blood and faecal samples. In patients receiving Lactobacillus GG, the median (interquartile range) frequency of immunoglobulin-secreting cells, determined by enzyme-linked immunospot assay, increased in the IgA class from 1840 (690-2530) to 3480 (1030-13 170)/10(6) cells; p=0.02. Likewise the median (interquartile range) frequency of specific antibody-secreting cells against dietary antigens increased during the Lactobacillus GG therapy in the IgM class from 3.8 (1.4-5.0) to 11.2 (5.0-30.0)/10(6) cells; p=0.02. In addition, Lactobacillus GG therapy decreased the median (interquartile range) activity of faecal urease, which has been associated with mucosal tissue damage, from 40.3 (21.7-54.3) to 28.6 (24.5-49.4) nmol. min(-1) (mg protein)(-1); p=0.10, while, in patients receiving bovine colostrum, faecal urease activity increased (from 42.2 to 80.6; p=0.04). All findings were transient. We suggest that gut defence mechanisms are disturbed in juvenile chronic arthritis and we further suggest that orally administered Lactobacillus GG has a potential to reinforce the mucosal barrier mechanisms in juvenile chronic arthritis.

References

  1. Lancet. 1986 Feb 1;1(8475):236-8 - PubMed
  2. Agents Actions. 1992 Sep;37(1-2):70-9 - PubMed
  3. Br J Rheumatol. 1987 Oct;26(5):329-33 - PubMed
  4. Pediatr Res. 1990 Dec;28(6):582-6 - PubMed
  5. Dig Dis Sci. 1994 Dec;39(12):2595-600 - PubMed
  6. Dig Dis Sci. 1992 Jan;37(1):121-8 - PubMed
  7. Gastroenterology. 1989 Dec;97(6):1562-84 - PubMed
  8. J Rheumatol. 1979 Mar-Apr;6(2):163-73 - PubMed
  9. Pediatr Res. 1992 Aug;32(2):141-4 - PubMed
  10. Infect Immun. 1991 Mar;59(3):996-1001 - PubMed
  11. Gastroenterology. 1993 Dec;105(6):1643-50 - PubMed
  12. Am J Gastroenterol. 1988 Mar;83(3):216-23 - PubMed
  13. Med Microbiol Immunol. 1992;181(2):87-98 - PubMed
  14. Scand J Immunol. 1991 Feb;33(2):225-9 - PubMed
  15. Br J Rheumatol. 1987 Apr;26(2):103-7 - PubMed
  16. Dig Dis Sci. 1986 Sep;31(9 Suppl):147S-162S - PubMed
  17. J Clin Microbiol. 1982 Feb;15(2):308-11 - PubMed
  18. J Rheumatol. 1987 Jun;14(3):459-65 - PubMed
  19. Biotherapy. 1992;5(3):215-25 - PubMed
  20. Gastroenterology. 1981 Apr;80(4):776-82 - PubMed
  21. Gut. 1975 Apr;16(4):318-23 - PubMed
  22. Gut. 1967 Dec;8(6):574-81 - PubMed
  23. Pediatr Infect Dis J. 1993 Aug;12(8):664-71 - PubMed
  24. Ann Nutr Metab. 1996;40(3):137-45 - PubMed
  25. Br J Rheumatol. 1996 Jul;35(7):689-94 - PubMed
  26. Adv Immunol. 1987;40:153-245 - PubMed
  27. Lancet. 1992 Jan 11;339(8785):89-91 - PubMed
  28. J Rheumatol. 1985 Apr;12(2):299-305 - PubMed
  29. Scand J Rheumatol. 1982;11(1):33-8 - PubMed
  30. Microbiol Rev. 1989 Mar;53(1):85-108 - PubMed
  31. Lancet. 1991 Oct 12;338(8772):899-902 - PubMed
  32. J Appl Bacteriol. 1989 May;66(5):365-78 - PubMed
  33. Pediatrics. 1991 Jul;88(1):90-7 - PubMed
  34. Clin Gastroenterol. 1983 Sep;12(3):767-95 - PubMed
  35. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  36. J Infect Dis. 1987 Jul;156(1):158-66 - PubMed
  37. Cell Immunol. 1989 Aug;122(1):131-45 - PubMed
  38. Lancet. 1988 Jan 16;1(8577):81-3 - PubMed
  39. Gut. 1992 Jul;33(7):987-93 - PubMed
  40. Gastroenterology. 1984 Jan;86(1):174-93 - PubMed
  41. Br J Rheumatol. 1994 Nov;33(11):1030-8 - PubMed
  42. Pediatr Clin North Am. 1988 Feb;35(1):1-15 - PubMed
  43. Infect Immun. 1984 May;44(2):474-8 - PubMed
  44. Ann Rheum Dis. 1992 Mar;51(3):298-302 - PubMed
  45. Eur J Pediatr. 1979;132(4):239-52 - PubMed
  46. J Infect Dis. 1986 Jun;153(6):1126-31 - PubMed
  47. J Rheumatol. 1990 Mar;17(3):291-4 - PubMed
  48. Cancer Res. 1986 Nov;46(11):5529-32 - PubMed
  49. Clin Exp Allergy. 1996 Feb;26(2):181-7 - PubMed

Publication Types